---
title: President's Science Award (PSA)
permalink: /winners/2018/psa/
description: ""
third_nav_title: "2018"
variant: markdown
---
<img src="/images/Winners/2018/psa-prof-loh-teck-peng.jpg" alt="Professor Loh Teck Peng" style="width:400px" align="left"><br><br><br><br><br><br><br><br><br><br><br>

### **Professor Loh Teck Peng**

<b>Professor,</b> School of Physical &amp; Mathematical Sciences, Nanyang Technological University, Singapore

<b>“For his outstanding research accomplishments in advancing organic chemistry and green chemistry that have far-reaching implications in fields such as pharmaceuticals, biotechnology and nanotechnology” </b> [Download Full Citation](/files/Citations/2018/2018-psa-professor-loh-teck-peng.pdf)
<br><br><br>

Team comprising:
Professor Tan Eng King
Deputy Medical Director (Academic Affairs), National Neuroscience Institute
Senior Consultant, Neurology, National Neuroscience Institute Director,
Research, National Neuroscience Institute Professor,
Programme in Neuroscience &amp; Behavioural Disorders,
Duke-NUS Medical School Co-Director,
American Parkinson’s Disease Foundation International Center of Excellence (National Neuroscience Institute) Associate Designated Institutional Official (Research),
SingHealth Residency Academic Vice Chair (Research), Neuroscience Academic Clinical Program

Associate Professor Lim Kah Leong
Head, Department of Physiology
Yong Loo Lin School of Medicine
National University of Singapore
Visiting Lead Scientist, National Neuroscience Institute
Associate Professor, Duke-NUS Medical School

Professor Ng Huck Hui
Executive Director
Genome Institute of Singapore, A*STAR

Associate Professor Louis Tan
Senior Consultant, Neurology, National Neuroscience Institute
Deputy Director, Research, National Neuroscience Institute Academic
Deputy Vice Chair (Research), Neuroscience Academic Clinical Program


“For outstanding contribution in the field of Parkinson’s Disease, galvanising clinical research and transforming patient care through the identification of clinical biomarkers, development of novel models and therapeutics.”
